Superfund Research Program

Meghan E. Rebuli

University of North Carolina-Chapel Hill
4310 Mary Ellen Jones
116 Manning Drive
CB#7325
Chapel Hill, North Carolina 27599-7142
Phone: 919-966-6898
Email: meradfor@email.unc.edu

Projects

• University of North Carolina-Chapel Hill: Research Experience and Training Coordination Core (RETCC) (2020-2025)

Publications

• Silveyra P, Al Houssein H, Rebuli ME. Sex and Gender Differences In The Susceptibility to Environmental Exposures. Chapter 9 in: Sex-Based Differences in Lung Physiology. Springer, (accepted for publication)

2023

• Payton A, Roell K, Rebuli ME, Valdar W, Rager JE. 2023. Navigating the bridge between wet and dry lab toxicology research to address current challenges with high-dimensional data. Front Toxicol 5:1171175. doi:10.3389/ftox.2023.1171175 PMID:37304253 PMCID:PMC10250703

2022

• Hsiao Y, Liu C, Robinette C, Knight N, Lu K, Rebuli ME. 2022. Development of LC-HRMS untargeted analysis methods for nasal epithelial lining fluid exposomics. J Expo Sci Environ Epidemiol doi:10.1038/s41370-022-00448-3
• Islam T, Braymiller J, Eckel SP, Tackett AP, Rebuli ME, Barrington-Trimis J, McConnell R. 2022. Secondhand nicotine vaping at home and respiratory symptoms in young adults. Thorax doi:10.1136/thoraxjnl-2021-217041 PMID:35013000
• Payton A, Perryman AN, Hoffman JR, Avula V, Wells H, Robinette C, Alexis N, Jaspers I, Rager JE, Rebuli ME. 2022. Cytokine signature clusters as a tool to compare changes associated with tobacco product use in upper and lower airway samples. Am J Physiol Lung Cell Mol Physiol 322(5):L722-L736. doi:10.1152/ajplung.00299.2021 PMID:35318855 PMCID:PMC9054348
• Tackett A, Rebuli ME. 2022. Alternative Flavored Inhalable Products-A New Respiratory Hazard?. Toxicol Sci 187(1):1-2. doi:10.1093/toxsci/kfac021 PMID:35472170 PMCID:PMC9041544

2021

• Escobar YH, Morrison CB, Chen Y, Hickman E, Love CA, Rebuli ME, Surratt JD, Ehre C, Jaspers I. 2021. Differential responses to e-cig generated aerosols from humectants and different forms of nicotine in epithelial cells from non-smokers and smokers. Am J Physiol Lung Cell Mol Physiol 320:L1064-L1073. doi:10.1152/ajplung.00525.2020 PMID:33825493 PMCID:PMC8285624
• Rebuli ME, Brocke SA, Jaspers I. 2021. Impact of inhaled pollutants on response to viral infection in controlled exposures. Journal of Allergy and Clinical Immunology 148(6):doi:10.1016/j.jaci.2021.07.002 PMID:34252446 (ahead of print)
• Rebuli ME, Glista-Baker E, Hoffman JR, Duffney PF, Robinette C, Speen AM, Pawlak EA, Dhingra R, Noah TL, Jaspers I. 2021. Electronic-cigarette use alters nasal mucosal immune response to live-attenuated influenza virus: A clinical trial. Am J Respir Cell Mol Biol 64(1):126-137. doi:10.1165/rcmb.2020-0164OC PMID:33095645 PMCID:PMC7781000

2020

• Rebuli ME. 2020. Why males may have a worse response to COVID-19. (non-peer reviewed)

2016

• Martin EM, Clapp PW, Rebuli ME, Pawlak EA, Glista-Baker E, Benowitz NL, Fry RC, Jaspers I. 2016. E-cigarette use results in suppression of immune and inflammatory-response genes in nasal epithelial cells similar to cigarette smoke. Am J Physiol 311(1):L135-L144. doi:10.1152/ajplung.00170.2016 PMID:27288488 PMCID:PMC4967187